mRNA delivery in cancer immunotherapy
Acta Pharmaceutica Sinica B · 2023-04 · 13 (4) · 1348-1357
DOI: 10.1016/j.apsb.2023.03.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-04. Verfasst von Yichen Zhong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of General Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
- Icahn Genomics Institute, Precision Immunology Institute, Department of Oncological Sciences, Tisch Cancer Institute, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Department of Radiation Oncology, Department of Biomedical Engineering, Center for Clinical and Translational Science, Comprehensive Cancer Center, Dorothy M. Davis Heart & Lung Research Institute, Center for Cancer Eng…
Förderung
- National Institute of General Medical Sciences
Zitieren
APA
Zhong, Y., Du, S., & Dong, Y. (2023). mRNA delivery in cancer immunotherapy. Acta Pharmaceutica Sinica B, 13(4), 1348-1357. https://doi.org/10.1016/j.apsb.2023.03.001
Vancouver
Zhong Y, Du S, Dong Y. mRNA delivery in cancer immunotherapy. Acta Pharmaceutica Sinica B. 2023;13(4):1348-1357. doi:10.1016/j.apsb.2023.03.001
BibTeX
@article{Zhong2023,
author = {Zhong, Yichen and Du, Shi and Dong, Yizhou},
title = {mRNA delivery in cancer immunotherapy},
journal = {Acta Pharmaceutica Sinica B},
year = {2023},
volume = {13},
number = {4},
pages = {1348--1357},
doi = {10.1016/j.apsb.2023.03.001}
}
EUVIMED